Medicine
Volume 36, Issue 1 , Pages 29-32 , January 2008

Hormonal therapy for cancer

References 

  1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) . Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–1717
  2. Saadat M, Truong PT, Kader HA, et al. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer: comparison of cohorts treated with and without tamoxifen. Cancer. 2007;110:31–37
  3. Royal College of Physicians, the Bone and Tooth Society, the National Osteoporosis Society . Glucocorticoid-induced osteoporosis: Guidelines for prevention and treatment. London: RCP; 2002;
  4. Burns-Cox N, Basketter V, Higgins B, et al. Prospective randomised trial comparing diethylstilboestrol and flutamide in the treatment of hormone relapsed prostate cancer. Int J Urol. 2002;9:431–434
  5. Hanks GE, Pajak TF, Porter A, et al. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92–02. J Clin Oncol. 2003;21:3972–3978

PII: S1357-3039(07)00352-0

doi: 10.1016/j.mpmed.2007.10.010

Medicine
Volume 36, Issue 1 , Pages 29-32 , January 2008